Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALLOPURINOL Cause Product prescribing error? 94 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 94 reports of Product prescribing error have been filed in association with ALLOPURINOL (Allopurinol). This represents 0.5% of all adverse event reports for ALLOPURINOL.

94
Reports of Product prescribing error with ALLOPURINOL
0.5%
of all ALLOPURINOL reports
3
Deaths
87
Hospitalizations

How Dangerous Is Product prescribing error From ALLOPURINOL?

Of the 94 reports, 3 (3.2%) resulted in death, 87 (92.6%) required hospitalization, and 5 (5.3%) were considered life-threatening.

Is Product prescribing error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALLOPURINOL. However, 94 reports have been filed with the FAERS database.

What Other Side Effects Does ALLOPURINOL Cause?

Drug reaction with eosinophilia and systemic symptoms (2,943) Acute kidney injury (1,583) Rash (1,103) Off label use (921) Pyrexia (913) Dyspnoea (905) Toxic epidermal necrolysis (858) Pruritus (836) Diarrhoea (819) Drug ineffective (780)

What Other Drugs Cause Product prescribing error?

SOMATROPIN (1,123) SACUBITRIL\VALSARTAN (1,023) SECUKINUMAB (821) TOFACITINIB (805) DUPILUMAB (725) NIRMATRELVIR\RITONAVIR (611) PREGABALIN (476) METHOTREXATE (434) TORSEMIDE (352) METOPROLOL (325)

Which ALLOPURINOL Alternatives Have Lower Product prescribing error Risk?

ALLOPURINOL vs ALMOTRIPTAN ALLOPURINOL vs ALMOTRIPTAN MALATE ALLOPURINOL vs ALOE VERA LEAF ALLOPURINOL vs ALOGLIPTIN ALLOPURINOL vs ALOGLIPTIN\METFORMIN

Related Pages

ALLOPURINOL Full Profile All Product prescribing error Reports All Drugs Causing Product prescribing error ALLOPURINOL Demographics